VIVO Cannabis Inc.: VIVO Cannabis Launches Premium Topical CBD Cream Infused with Terpenes: Unique Formulation Designed for Medical Users
VIVO Cannabis Inc. (
VIVO or the
Company ), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ( Canna Farms ) and ABcann Medicinals Inc. ( ABcann ), today announced the launch of Beacon Medical
Extra Strength CBD|T Cream, an innovative, premium cannabis topical cream for Canadian medical patients. With 500 mg of cannabidiol (CBD) per 50-gram unit, in a proprietary formulation that includes carefully curated ingredients with anti-oxidant, anti-inflammatory, and analgesic properties, together with skin penetration enhancers, Beacon Medical Extra Strength CBD|T Cream is designed using entourage principles to achieve synergies of bioactive ingredients and provide optimal symptom relief for medical conditions.